Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.

By F. Cutts, Syed M. A. Zaman, G. Enwere, S. Jaffar, Orin S. Levine, J. B. Okoko, C. Oluwalana, Adeola Vaughan, S. Obaro, A. Leach and 8 more. The Lancet, 2005

924 citations recorded by the source corpus.

Subfields: Epidemiology, Microbiology

View Paper: https://www.semanticscholar.org/paper/6884e36dd13539c41b419503e0326873f5751940

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Jonathan A. McCullers
2. Marc Lipsitch

Citations in the corpus

• Insights into the Interaction between Influenza Virus and Pneumococcus (2006, background): “The burden of pneumococcal disease in both adults and children in developing countries where the vaccine is not available is considerably higher than that in the United States (11, 18, 33, 44).”
• Serotype replacement in disease following pneumococcal vaccination: A discussion of the evidence (2011, positive): “In light of this record and of clinical trials performed in developing countries showing substantial benefits [9–11], there is a strong movement to introduce conjugate vaccines more widely throughout the world.”